Fowler CJ et al. |
Inhibition of anandamide hydrolysis by the enantiomers of ibuprofen, ketorolac, and flurbiprofen. |
1999 |
Arch. Biochem. Biophys. |
pmid:9989926
|
Piomelli D et al. |
Endogenous cannabinoid signaling. |
1998 |
Neurobiol. Dis. |
pmid:9974178
|
Di Marzo V and Deutsch DG |
Biochemistry of the endogenous ligands of cannabinoid receptors. |
1998 |
Neurobiol. Dis. |
pmid:9974173
|
Navarro M and RodrÃguez de Fonseca F |
The neurobiology of cannabinoid transmission: from anandamide signaling to higher cerebral functions and disease. |
1998 |
Neurobiol. Dis. |
pmid:9974172
|
Lu R et al. |
Cloning of the human kidney PAH transporter: narrow substrate specificity and regulation by protein kinase C. |
1999 |
Am. J. Physiol. |
pmid:9950961
|
Goparaju SK et al. |
Enzymes of porcine brain hydrolyzing 2-arachidonoylglycerol, an endogenous ligand of cannabinoid receptors. |
1999 |
Biochem. Pharmacol. |
pmid:9933030
|
Wagner JA et al. |
Mesenteric vasodilation mediated by endothelial anandamide receptors. |
1999 |
Hypertension |
pmid:9931142
|
Basavarajappa BS and Hungund BL |
Chronic ethanol increases the cannabinoid receptor agonist anandamide and its precursor N-arachidonoylphosphatidylethanolamine in SK-N-SH cells. |
1999 |
J. Neurochem. |
pmid:9930723
|
Beltramo M and Piomelli D |
Anandamide transport inhibition by the vanilloid agonist olvanil. |
1999 |
Eur. J. Pharmacol. |
pmid:9920187
|
Sugiura T et al. |
Evidence that the cannabinoid CB1 receptor is a 2-arachidonoylglycerol receptor. Structure-activity relationship of 2-arachidonoylglycerol, ether-linked analogues, and related compounds. |
1999 |
J. Biol. Chem. |
pmid:9915812
|
Lin S et al. |
Novel analogues of arachidonylethanolamide (anandamide): affinities for the CB1 and CB2 cannabinoid receptors and metabolic stability. |
1998 |
J. Med. Chem. |
pmid:9876105
|
Ueda N et al. |
A hydrolase enzyme inactivating endogenous ligands for cannabinoid receptors. |
1998 |
J. Med. Invest. |
pmid:9864962
|
Bonhaus DW et al. |
Dual activation and inhibition of adenylyl cyclase by cannabinoid receptor agonists: evidence for agonist-specific trafficking of intracellular responses. |
1998 |
J. Pharmacol. Exp. Ther. |
pmid:9864268
|
Stahl SM |
Getting stoned without inhaling: anandamide is the brain's natural marijuana. |
1998 |
J Clin Psychiatry |
pmid:9862600
|
Mallet PE and Beninger RJ |
The cannabinoid CB1 receptor antagonist SR141716A attenuates the memory impairment produced by delta9-tetrahydrocannabinol or anandamide. |
1998 |
Psychopharmacology (Berl.) |
pmid:9862397
|
Pate DW et al. |
Effect of the CB1 receptor antagonist, SR141716A, on cannabinoid-induced ocular hypotension in normotensive rabbits. |
1998 |
Life Sci. |
pmid:9851310
|
Castellano C et al. |
The effects of anandamide on memory consolidation in mice involve both D1 and D2 dopamine receptors. |
1997 |
Behav Pharmacol |
pmid:9832956
|
Mechoulam R et al. |
Endocannabinoids. |
1998 |
Eur. J. Pharmacol. |
pmid:9831287
|
Maccarrone M et al. |
Anandamide hydrolysis by human cells in culture and brain. |
1998 |
J. Biol. Chem. |
pmid:9822713
|
Barnett-Norris J et al. |
Exploration of biologically relevant conformations of anandamide, 2-arachidonylglycerol, and their analogues using conformational memories. |
1998 |
J. Med. Chem. |
pmid:9822555
|